Yahoo Finance

J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge? (opens in new tab)

Covers 2 stories See all stories this covers including Corporate America Is Starting to Ration AI as Cost Skyrockets

Partnership strategy has produced great pharma bargains—and left the company exposed.

Read the original article
Sign in to keep reading the full article.
Sign UpLog In

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help